Aztreonam avibactam drug interactions are an important consideration when this intravenous antibacterial combination is used with other medicines. Current prescribing information identifies particular concern with organic anion transporter (OAT) 1 and OAT 3 inhibitors such as probenecid, while available data suggest that aztreonam-avibactam has relatively low interaction potential through major CYP enzymes and several hepatic...Read More